Latest Ratios: P/E Ratio 28.8x · EV/EBITDA N/A · ROE 3.7%. (2022–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $234M | $181M | — | — | — |
| Enterprise Value | $234M | $181M | — | — | — |
| P/E Ratio → | 28.84 | 28.35 | — | — | — |
| P/S Ratio | — | — | — | — | — |
| P/B Ratio | 1.05 | 1.03 | — | — | — |
| P/FCF | — | — | — | — | — |
| P/OCF | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — |
| EV / FCF | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | — | — | 69.9% | — | — |
| Operating Margin | — | — | -18.4% | — | — |
| Net Profit Margin | — | — | -6.7% | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | 3.7% | 3.7% | -0.1% | — | — |
| ROA | 3.6% | 3.6% | -0.1% | -221.1% | -16.2% |
| ROIC | -0.4% | -0.4% | -0.2% | -949.2% | — |
| ROCE | -0.5% | -0.5% | -0.2% | — | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | — | — |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | 0.00 | -0.00 | — | — |
| Net Debt / EBITDA | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — |
| Interest Coverage | — | — | -0.14 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.07 | 0.07 | 3.09 | 0.00 | 0.12 |
| Quick Ratio | 0.07 | 0.07 | 3.09 | 0.00 | 0.12 |
| Cash Ratio | 0.05 | 0.05 | 2.08 | 0.00 | 0.00 |
| Asset Turnover | — | — | 0.01 | — | — |
| Inventory Turnover | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | 3.5% | 3.5% | — | — | — |
| FCF Yield | — | — | — | — | — |
| Buyback Yield | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | — | — | — | — |
| Shares Outstanding | — | $17M | $4M | $4M | $4M |
Insolvency and delisting risk
According to recent SEC filings, TDAC's P/E ratio of 28.89 appears disconnected from its pre-revenue status, suggesting that market participants are pricing the entity as a speculative option on a future business combination rather than evaluating it based on any underlying fundamental earnings power or historical growth metrics.
The current P/E multiple is essentially meaningless for a shell company, as it likely reflects non-operating accounting adjustments rather than core profitability. Investors should monitor this valuation with extreme caution, as it lacks the support of revenue or cash flow, making it highly susceptible to rapid re-pricing if the market loses confidence in the likelihood of a successful merger.
Based on reported figures, TDAC's ROIC has hovered near zero or negative levels, reflecting the company's inability to deploy capital effectively since its 2022 incorporation, which indicates that the entity is currently failing to generate any meaningful return on the funds provided by sponsors or shareholders.
The lack of positive ROIC is a structural reality for a shell company that has yet to execute a transaction. This trend suggests that capital is being consumed by administrative overhead rather than being compounded, which warrants further investigation into whether the current management team can pivot toward a value-accretive acquisition.
As reported in financial statements, the current ratio has plummeted to 0.09 as of 2026Q1, highlighting a severe liquidity crunch that leaves the company with minimal cash reserves to cover its ongoing regulatory and administrative obligations without relying on external sponsor support or additional debt financing.
This liquidity profile suggests that the entity is in a precarious position where even minor unexpected expenses could trigger a solvency crisis. The reliance on sponsor-backed promissory notes to maintain operations indicates that the company's survival is currently contingent on external goodwill rather than internal financial strength.
As indicated by the financial data, the most commonly misapplied metric for TDAC is the P/E ratio, which obscures the reality that the company is a dormant shell rather than an operating business, and investors should instead focus on the 'time to liquidation' and cash burn rate.
Using traditional valuation multiples like P/E or P/B for a shell company is fundamentally flawed because these ratios assume a stable, revenue-generating business model. Instead, analysts should evaluate the entity based on its remaining cash runway and the probability of a successful de-SPAC transaction, as these are the only factors that will determine the ultimate value for shareholders.
Includes 30+ ratios · 4 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying TDAC stock.
Translational Development Acquisition Corp.'s current P/E ratio is 28.8x. The historical average is 28.4x. This places it at the 100th percentile of its historical range.
Translational Development Acquisition Corp.'s return on equity (ROE) is 3.7%. The historical average is 1.8%.
Based on historical data, Translational Development Acquisition Corp. is trading at a P/E of 28.8x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.